Dataset - CKAN

Development of an oral form of fondaparinux

Since its introduction in the market in 2002, fondaparinux (Arixtra®) is a drug of choice in the anticoagulant therapy. Its structure corresponds to the heparin...
- HTML

You can also access this registry using the API (see API Docs).